The MMRF Blog - Multiple Myeloma Research Foundation

The MMRF Blog

The effect of salvage autologous stem-cell transplantation on overall survival in patients with relapsed multiple myeloma (final results from BSBMT/UKMF Myeloma X Relapse [Intensive]): a randomised, open-label, phase 3 trial.

Cook G, Ashcroft AJ, Cairns DA, Williams CD, Brown JM, Cavenagh JD, Snowden JA, Parrish C, Yong K, Cavet J, Hunter H, Bird JM, Pratt G, Chown S, Heartin E, O'Connor S, Drayson MT, Hockaday A, Morris TC; National Cancer Research Institute Haemato-oncology Clinical Studies Group. Lancet Haematol. 2016 Jul;3(7):e340-51. doi: 10.1016/S2352-3026(16)30049-7. PMID: 27374467 [PubMed - in process] READ MORE

Posted: July 21, 2016

Autologous stem cell transplant for multiple myeloma patients 70 years or older.

Muchtar E, Dingli D, Kumar S, Buadi FK, Dispenzieri A, Hayman SR, Wolf RC, Gastineau DA, Chakraborty R, Hogan WJ, Leung N, Kapoor P, Lacy MQ, Rajkumar SV, Gertz MA. Bone Marrow Transplant. 2016 Jul 4. doi: 10.1038/bmt.2016.174. [Epub ahead of print] PMID: 27376447 [PubMed - as supplied by publisher] READ MORE

Posted: July 21, 2016

Impact of pre-transplant bone marrow plasma cell percentage on post-transplant response and survival in newly diagnosed multiple myeloma.

Chakraborty R, Muchtar E, Kumar SK, Buadi FK, Dingli D, Dispenzieri A, Hayman SR, Hogan WJ, Kapoor P, Lacy MQ, Leung N, Gertz MA. Leuk Lymphoma. 2016 Jul 7:1-8. [Epub ahead of print] PMID: 27390076 [PubMed - as supplied by publisher] READ MORE

Posted: July 21, 2016

Page 10 of 81« First...89101112...203040...Last »